3-Hydroxyfatty acid
metabolite3-Hydroxyfatty acid from LPS-containing lipoproteins activates innate immune sensors and plaque inflammation.
Pathway placement
Cascade stepPlaque inflammation
Confidencemedium
RationaleLPS-derived immunogenic lipid; activates innate immunity in plaque inflammation.
Druggability
Not assessed (no mapped human gene target).
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum, plasma or urine
Collection tube
Serum separator (gold/red-top, SST) · Lithium heparin (green-top) · Sterile urine container
Method / principle
LC-MS/MS (targeted metabolomics) or enzymatic colorimetric where available
Reagent / substrate
Stable-isotope-labeled internal standard (MS); or enzyme-coupled Trinder reagent
Platform
LC-MS/MS; some automated chemistry
Turnaround · availability
Send-out / research · Specialized / research
Literature evidence(1)
- Characterization of the LPS and 3OHFA Contents in the Lipoprotein Fractions and Lipoprotein Particles of Healthy Men.Biomolecules · 2021 · PMID 35053195 · doi